Tag - HSDT

Developments

Helius’ PoNS treatment gets FDA breakthrough designation for MS

Helius Medical Technologies’ (NASDAQ:HSDT; TSX:HSM) portable neuromodulation stimulator (PoNS) received FDA breakthrough designation for the treatment of gait deficit due to symptoms of multiple sclerosis (MS). The non...

May 12, 2020

Developments

Helius Medical adds new PoNS clinic in Quebec City

Helius Medical Technologies (NASDAQ:HSDT; TSX:HSM) is opening a new PoNS clinic in Quebec City, Canada to be operated by Clinique Cortex. The PoNS device is authorized in Canada for the acute treatment of chronic...

September 13, 2019

Tag - HSDT

Helius’ PoNS treatment gets FDA breakthrough designation for MS

Helius Medical adds new PoNS clinic in Quebec City

General

More